-
Posted: November 21st, 2023, 3:00am GMT
Conditions: Adrenal Cortical Carcinoma; Medullary Thyroid Cancer; Thymic Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Tumor
Interventions: Biological: individualized mRNA neoantigen vaccine (mRNA-0523-L001)
Sponsors: Shanghai Jiao Tong University School of Medicine
Not yet recruiting
-
Posted: November 16th, 2023, 3:00am GMT
Conditions: Breast Cancer; Oligometastasis; Metastatic Breast Cancer
Interventions: Drug: Systemic therapy for 12 weeks after primary registration; Procedure: Radiation therapy (SBRT/conventional RT); Procedure: Surgery; Drug: Same systemic therapy after secondary registration
Sponsors: Tokyo Medical and Dental University
Recruiting
-
Posted: November 15th, 2023, 3:00am GMT
Conditions: Low Grade Glioma; Malignant Brain Glioma; Malignant Brain Neoplasm; Meningioma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Magnetic Resonance Imaging; Other: Questionnaire Administration
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: November 9th, 2023, 3:00am GMT
Conditions: Extensive Small Cell Lung Cancer
Interventions: Drug: Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
Sponsors: Qianfoshan Hospital
Recruiting
-
Posted: October 25th, 2023, 2:00am GMT
Conditions: Primary Aldosteronism Due to Aldosterone Producing Adenoma; Primary Aldosteronism; Adrenal Tumors
Interventions: Combination Product: 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
Sponsors: Changi General Hospital; National University Health System, Singapore; Clinical Imaging Research Centre; Singapore General Hospital; Tan Tock Seng Hospital; Khoo Teck Puat Hospital; Ng Teng Fong General Hospital; Sengkang General Hospital
Recruiting
-
Posted: October 19th, 2023, 2:00am GMT
Conditions: Hyperaldosteronism; Hypertension; Aldosterone-producing Adenoma; Aldosteronism; Aldosterone Disorder; Essential Hypertension; Bilateral Adrenal Hyperplasia; Conn Adenoma
Interventions: Procedure: Skin Biopsy; Procedure: Video-laparoscopic adrenalectomy
Sponsors: University Hospital Padova
Recruiting
-
Posted: October 5th, 2023, 2:00am GMT
Conditions: Thyroid Cancer, Papillary; Primary Aldosteronism
Interventions: Diagnostic Test: Secreening test for primary aldosteronism and Confirmatory Testing
Sponsors: Instituto do Cancer do Estado de São Paulo; Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed
-
Posted: October 4th, 2023, 2:00am GMT
Conditions: Adrenocortical Carcinoma; ACC; Metastatic Adrenocortical Carcinoma
Interventions: Radiation: Ablative Radiotherapy; Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
-
Posted: October 4th, 2023, 2:00am GMT
Conditions: Adenine Phosphoribosyltransferase Deficiency; AH Amyloidosis; AHL Amyloidosis; AL Amyloidosis; Alport Syndrome; Atypical Hemolytic Uremic Syndrome; Autoimmune Distal Renal Tubular Acidosis; Autosomal Recessive Proximal Renal Tubular Acidosis; Autosomal Recessive Distal Renal Tubular Acidosis; Autosomal Dominant Polycystic Kidney Disease; Autosomal Recessive Polycystic Kidney Disease; Bartter Syndrome; BK Nephropathy; C3 Glomerulopathy With Monoclonal Gammopathy; C3 Glomerulopathy; Calciphylaxis; Crystalglobulinaemia; Crystal-storing Histiocytosis; Cystinosis; Cystinuria; Dense Deposit Disease; Dent Disease; Denys-Drash Syndrome; Dominant Hypophosphataemia With Nephrolithiasis and/or Osteoporosis; Drug Induced Fanconi Syndrome; Drug-Induced Hypomagnesemia; Drug-Induced Nephrogenic Diabetes Insipidus; Epilepsy, Ataxia, Sensorineural Deafness and Tubulopathy; Fabry Disease; Familial Hypomagnesemia With Hypercalciuria and Nephrocalcinosis; Familial Primary Hypomagnesemia With Hypocalcuria; Familial Primary Hypomagnesaemia With Normocalciuria; Familial Renal Glucosuria; Fanconi Renotubular Syndrome 1; Fanconi Renotubular Syndrome 2; Fanconi Renotubular Syndrome 3; Fibrillary Glomerulonephritis; Fibromuscular Dysplasia; Focal Segmental Glomerulosclerosis; Generalised Pseudohypoaldosteronism Type 1; Gitelman Syndrome; Heavy-Metal-Induced Fanconi Syndrome; Hepatocyte Nuclear Factor 1-Beta-Associated Monogenic Diabetes; Hereditary Renal Hypouricemia; Hereditary Hypophosphatemic Rickets With Hypercalciuria; Hyperuricaemic Nephropathy; IgA Nephropathy; Immunotactoid Glomerulonephritis With Organised Microtubular Mononoclonal Immunoglobulin Deposits; Inherited Renal Cancer Syndromes; Intracapillary Monoclonal IgM Without Cryoglobulin; Intraglomerular/Capillary Lymphoma/Leukaemia; Isolated Autosomal Dominant Hypomagnesaemia Glaudemans Type; Liddle Syndrome; Light Chain Cast Nephropathy; Light Chain Proximal Tubulopathy Without Crystals; Light Chain Proximal Tubulopathy With Crystals; Lowe Syndrome; Membranous Nephropathy; Membranoproliferative Glomerulonephritis; Medullary Cystic Kidney Disease; Minimal Change Nephropathy; Mitochondrial Disease Of The Kidney; Monoclonal Immunoglobulin Deposition Disease; Nail Patella Syndrome; Nephrogenic Diabetes Insipidus; Nephrogenic Syndrome of Inappropriate Antidiuresis; Nephronophthisis; Primary Hypomagnesemia With Secondary Hypocalcemia; Primary Hyperoxaluria; Proliferative Glomerulonephritis With Monoclonal IgG Deposits; Proximal Tubulopathy Without Crystals; Pseudohypoaldosteronism Type 1, 2A-2E; Pure Red Cell Aplasia; Retroperitoneal Fibrosis; Sickle Cell Nephropathy; Shiga Toxin Associated Haemolytic Uraemic Syndrome; Steroid Resistant Nephrotic Syndrome; Steroid-Sensitive Nephrotic Syndrome; Thin Basement Membrane Nephropathy; Thrombotic Microangiopathy With Monoclonal Gammopathy; Type 1 Cryoglobulinaemic Glomerulonephritis; Tuberous Sclerosis; Unclassified Monoclonal Gammopathy Of Renal Significance; Vasculitis
Sponsors: UK Kidney Association
Recruiting
-
Posted: October 2nd, 2023, 2:00am GMT
Conditions: Pheochromocytoma; Non-Secretory Adrenal Adenoma
Interventions: Procedure: adrenalectomy
Sponsors: Central Hospital, Nancy, France
Recruiting
-
Posted: September 27th, 2023, 2:00am GMT
Conditions: Postoperative Bleeding; Skin Cancer Face
Interventions: Drug: Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine); Drug: Control (1% lidocaine with 1:100,000 epinephrine)
Sponsors: Vanderbilt University Medical Center
Not yet recruiting
-
Posted: September 27th, 2023, 2:00am GMT
Conditions: Neuroendocrine Tumors
Interventions: Diagnostic Test: Al18F-NOTA-LM3; Diagnostic Test: 68Ga-DOTATATE; Diagnostic Test: Al18F-NOTA-LM3; Diagnostic Test: 68Ga-NODAGA-LM3
Sponsors: Peking Union Medical College Hospital
Recruiting
-
Posted: September 22nd, 2023, 2:00pm GMT
Conditions: Adrenal Tumor; Adrenal Disease; Adrenal Mass; Adrenalectomy; Status; Adrenal Hyperplasia; Adrenal Gland Metastasis; Adrenal Cortex Diseases; Pheochromocytoma; Cushing Syndrome; Conn Adenoma; Adrenocortical Carcinoma; Adrenocortical Adenoma; Adrenocortical Tumor
Sponsors: University Hospital Olomouc; University Hospital Ostrava; Tomas Bata Hospital, Czech Republic; General University Hospital, Prague; University Hospital Hradec Kralove
Recruiting
-
Posted: September 18th, 2023, 2:00pm GMT
Conditions: Neuroendocrine Carcinomas; Neuroendocrine Tumors; Carcinoma, Neuroendocrine; Carcinoma, Adrenocortical; Carcinoma, Adrenal Cortical
Interventions: Drug: ADCT-701
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: September 14th, 2023, 2:00am GMT
Conditions: Pheochromocytoma
Interventions: Drug: dexmedetomidine; Drug: 0.9% normal saline
Sponsors: Yonsei University
Completed
-
Posted: September 11th, 2023, 2:00am GMT
Conditions: Cerebral Adrenoleukodystrophy
Interventions: Biological: Mesenchymal stem cells (IV-MSC)
Sponsors: Masonic Cancer Center, University of Minnesota
Recruiting
-
Posted: September 8th, 2023, 2:00am GMT
Conditions: Chronic Low-back Pain; Older Adults; Core Stabilization Exercise Therapy
Interventions: Behavioral: core stabilization exercise
Sponsors: The Hong Kong Polytechnic University
Recruiting
-
Posted: September 6th, 2023, 2:00pm GMT
Conditions: Breast Neoplasms
Interventions: Procedure: Cold dissection; Procedure: Electrocautery Dissection
Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Recruiting
-
Posted: August 28th, 2023, 2:00pm GMT
Conditions: Hypopituitarism; Radiotherapy-Induced Hypopituitarism; Brain Tumor
Intervention: Diagnostic Test: Dynamic testing of Pituitary Function
Sponsors: Royal College of Surgeons, Ireland; Beaumont Hospital
Not yet recruiting
-
Posted: August 23rd, 2023, 2:00pm GMT
Conditions: Locally Advanced Adrenal Cortex Carcinoma; Adrenal Cortical Carcinoma; Stage III Adrenal Cortex Carcinoma; Stage IV Adrenal Cortex Carcinoma AJCC v8; Unresectable Adrenal Cortex Carcinoma
Interventions: Biological: Atezolizumab; Procedure: Biospecimen Collection; Drug: Cabozantinib S-malate; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging
Sponsors: Emory University; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: August 22nd, 2023, 2:00pm GMT
Condition: Cognitive Function
Interventions: Drug: acetaminophen mannitol; Drug: Normal saline
Sponsor: Affiliated Hospital of Nantong University
Recruiting
-
Posted: August 21st, 2023, 2:00am GMT
Conditions: Adrenocortical Carcinoma
Interventions: Drug: 68Ga-R8760 injection at pre-defined dose levels; Drug: 68Ga-R8760 injection
Sponsors: Radionetics Oncology
Recruiting
-
Posted: August 14th, 2023, 2:00am GMT
Conditions: Uterine Fibroid
Interventions: Drug: Carbetocin
Sponsors: Egymedicalpedia
Completed
-
Posted: August 8th, 2023, 2:00pm GMT
Conditions: Recurrent Multiple Myeloma; Refractory Multiple Myeloma
Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Drug: Dexamethasone; Procedure: Echocardiography; Biological: Elotuzumab; Procedure: Magnetic Resonance Imaging; Biological: Mezigdomide; Procedure: X-Ray Imaging
Sponsors: Abdullah Khan
Recruiting
-
Posted: August 7th, 2023, 2:00pm GMT
Conditions: Colorectal Cancer; CRC; Behavior
Intervention: Behavioral: mHealth Application
Sponsors: Virginia Commonwealth University; National Cancer Institute (NCI)
Recruiting
-
Posted: August 1st, 2023, 2:00am GMT
Conditions: Stellate Ganglion Block; Cervical Epidural; Complex Regional Pain Syndromes
Interventions: Drug: Ultrasound guided Stellate ganglion block; Drug: unilateral cervical epidural
Sponsors: Tanta University
Recruiting
-
Posted: July 19th, 2023, 2:00am GMT
Conditions: Polycystic Ovary Syndrome; Obesity; Infertility, Female
Interventions: Drug: Liraglutide + Metformin; Drug: Metformin
Sponsors: Mỹ Đức Hospital
Not yet recruiting
-
Posted: July 11th, 2023, 2:00pm GMT
Conditions: Left-sided Pancreatic Cancer
Interventions: Procedure: LRAMPS; Procedure: LDP
Sponsors: Fudan University; The Third Affiliated Hospital of Soochow University; Qilu Hospital of Shandong University
Recruiting
-
Posted: June 15th, 2023, 2:00pm GMT
Conditions: Postoperative Pain, Acute; Postoperative Complications
Interventions: Procedure: Thoracic epidural catheter; Procedure: Local intercostal nerve block; Procedure: Cryo-analgesia and intercostal nerve block; Procedure: Serratus plane catheter blocks and intercostal nerve blocks
Sponsor: Swedish Medical Center
Recruiting
-
Posted: June 9th, 2023, 2:00pm GMT
Conditions: Thoracic Surgery; Video-Assisted; Cryotherapy Effect; Paravertebral Block
Interventions: Procedure: Cryoanalgesia AND single-injection paravertebral block; Procedure: Single-injection paravertebral block
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting
-
Posted: June 1st, 2023, 2:00pm GMT
Conditions: Cryotherapy Effect; Chronic Pain; Lung Cancer; Surgery
Interventions: Procedure: Cryoanalgesia AND single-injection paravertebral block; Procedure: Single-injection paravertebral block
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM)
Recruiting
-
Posted: May 23rd, 2023, 2:00pm GMT
Conditions: Hepatocellular Carcinoma
Interventions: Diagnostic Test: 18F-FDGal PET/CT or PET/MRI
Sponsors: University of Aarhus
Recruiting
-
Posted: May 2nd, 2023, 2:00pm GMT
Condition: Aldosterone-Producing Adenoma
Intervention: Diagnostic Test: CXCR4
Sponsor: Zhongnan Hospital
Recruiting
-
Posted: April 28th, 2023, 2:00pm GMT
Conditions: Squamous Cell Carcinoma of the Head and Neck; Paclitaxel; Carboplatin; Nivolumab
Intervention: Drug: GCP intratumoral catheter
Sponsor: Centre Hospitalier Universitaire, Amiens
Not yet recruiting
-
Posted: April 25th, 2023, 2:00am GMT
Conditions: Secondary Adrenal Insufficiency; Fasting, Intermittent
Interventions: Behavioral: education and drug adjustement
Sponsors: Hopital La Rabta
Active, not recruiting
-
Posted: April 18th, 2023, 2:00pm GMT
Conditions: Bleeding
Interventions: Drug: Sucralfate
Sponsors: National Cheng-Kung University Hospital
Recruiting
-
Posted: April 10th, 2023, 2:00pm GMT
Conditions: Misoprostol Allergy; Oxytocin Allergy; Tranexamic Acid Allergy; Ethamsylate Allergy; Myoma; Blood Loss, Surgical
Interventions: Drug: Misoprostol; Device: Tourniquet; Drug: Carbetocin; Drug: Oxytocin; Drug: combined TXA and ethamsylate; Drug: Vasopressin; Drug: Bupivacaine Hydrochloride 0.5 % Injectable Solution epinephrine
Sponsor: Cairo University
Recruiting
-
Posted: April 7th, 2023, 2:00am GMT
Conditions: Cushing Syndrome; Cushing Disease; Ectopic ACTH Syndrome
Interventions: Drug: CRN04894
Sponsors: Crinetics Pharmaceuticals Inc.
Recruiting
-
Posted: March 29th, 2023, 2:00pm GMT
Condition: Portal Thrombosis
Intervention:
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
-
Posted: March 24th, 2023, 2:00pm GMT
Conditions: Patient With Radiotherapy (Linac MRI); Mobile Cancerous Lesion
Interventions: Combination Product: With non-magnetic screen
Sponsors: Centre Georges Francois Leclerc
Recruiting
-
Posted: March 24th, 2023, 2:00pm GMT
Conditions: Oligometastatic Disease; Oligoprogression; Toxicity Due to Radiotherapy; Quality of Life
Interventions: Radiation: Single fraction SABR; Radiation: Multiple fraction SABR; Other: QoL reporting alone; Other: QoL reporting, symptom screen and healthcare provider intervention
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Tom Baker Cancer Centre; Princess Margaret Hospital, Canada
Not yet recruiting
-
Posted: March 23rd, 2023, 2:00pm GMT
Condition: Neuroblastoma
Interventions: Other: Immersive virtual reality imaging; Other: Gold standard imaging
Sponsor: Hospital Sant Joan de Deu
Recruiting
-
Posted: March 10th, 2023, 3:00pm GMT
Condition: Adrenocortical Carcinoma
Intervention: Procedure: Adrenalectomy with or without lymphadenectomy
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
-
Posted: March 6th, 2023, 3:00pm GMT
Conditions: Cancer; Adrenal
Interventions: Other: Blood sample; Other: Urine sample; Other: Tumor sample
Sponsors: Assistance Publique - Hôpitaux de Paris; National Cancer Institute, France
Not yet recruiting
-
Posted: March 6th, 2023, 3:00pm GMT
Conditions: Breast Cancer Screening; Colorectal Cancer Screening; Implementation
Intervention: Other: Practice-Level Implementation Strategies
Sponsors: Harvard School of Public Health (HSPH); National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting
-
Posted: March 1st, 2023, 3:00pm GMT
Conditions: Liver Transplant Disorder; Hepatic Cancer; End-stage Liver Disease
Intervention: Procedure: assisted liver transplantation combined with two-stage hepatectomy
Sponsors: RenJi Hospital; The Affiliated Hospital of Qingdao University; The First Affiliated Hospital of Zhengzhou University
Not yet recruiting
-
Posted: February 27th, 2023, 3:00pm GMT
Condition: Sleep Disorder, Lung Tumor
Intervention:
Sponsor: RenJi Hospital
Not yet recruiting
-
Posted: February 24th, 2023, 3:00pm GMT
Conditions: Diagnosis; Treatment; Adrenogenic Autonomic Cortisol Secretion
Intervention:
Sponsor: Chongqing Medical University
Not yet recruiting
-
Posted: February 22nd, 2023, 3:00pm GMT
Conditions: Renal Cell Carcinoma; Adrenal Tumor; Nonfunctioning Kidney; Renal Pelvis Carcinoma; Ureteral Tumor; Bladder Cancer; Prostate Cancer; Pelvic Tumor; Renal Cyst; Duplex Kidney; Renal Calculi; Ureteral Calculi; Ureteropelvic Junction Obstruction; Penile Cancer
Intervention: Device: telesurgery by domestic surgical robot
Sponsor: The Affiliated Hospital of Qingdao University
Recruiting
-
Posted: January 18th, 2023, 3:00pm GMT
Conditions: Gastric Polyp; Gastric Neoplasm; Duodenal Neoplasms; Esophageal Neoplasms
Interventions: Drug: Tranexamic acid; Drug: Epinephrine injection
Sponsor: Assaf-Harofeh Medical Center
Recruiting
-
Posted: January 18th, 2023, 3:00am GMT
Conditions: Congenital Adrenal Hyperplasia; Familial Hyperinsulinemic Hypoglycemia 1; Phosphoglucomutase 1 Deficiency; Maturity Onset Diabetes of the Young; Cystic Fibrosis; Hypophosphatasia, Infantile; Congenital Hypothyroidism; Deficit in Anterior Pituitary Function and Variable Immunodeficiency; Pituitary Hormone Deficiency, Combined; Diamond Blackfan Anemia; Wiskott-Aldrich Syndrome; Fanconi Anemia; Hemophilia A; Hemophilia B; Glucose 6 Phosphate Dehydrogenase Deficiency; Alpha-Thalassemia; Sickle Cell Disease; Shwachman-Diamond Syndrome; Alpha 1-Antitrypsin Deficiency; Inflammatory Bowel Disease 25, Autosomal Recessive; Wilson Disease; Progressive Familial Intrahepatic Cholestasis; Crigler-Najjar Syndrome; Familial Chylomicronemia; Lysosomal Acid Lipase Deficiency; Familial Hemophagocytic Lymphocytosis; Griscelli Syndrome; Chediak-Higashi Syndrome; Severe Congenital Neutropenia; Severe Combined Immune Deficiency; Chronic Granulomatous Disease; Menkes Disease; Adrenoleukodystrophy; Smith-Lemli-Opitz Syndrome; Ataxia With Vitamin E Deficiency; Thiamine Metabolism Dysfunction Syndrome 5 (Episodic Encephalopathy Type); Thiamine Metabolism Dysfunction Syndrome 4 (Bilateral Striatal Degeneration and Progressive Polyneuropathy Type); Thiamine-Responsive Megaloblastic Anemia; Thiamine Metabolism Dysfunction Syndrome 2; Deficiency of GOT2; Cerebral Folate Transport Deficiency; Segawa Syndrome, Autosomal Recessive; Congenital Myasthenic Syndrome; Metachromatic Leukodystrophy; Sepiapterin Reductase Deficiency; Dopamine Beta Hydroxylase Deficiency; Glut1 Deficiency Syndrome; Late-Infantile Neuronal Ceroid Lipofuscinosis; Aromatic L-amino Acid Decarboxylase Deficiency; Charcot-Marie-Tooth Disease, Type 6C; Hereditary Hyperekplexia; Brain Dopamine-Serotonin Vesicular Transport Disease; Very Long Chain Hydroxy Acyl Dehydrogenase Deficiency; Tyrosinemia, Type I; Disaccharide Intolerance I; Beta Ketothiolase Deficiency; Phosphoglycerate Dehydrogenase Deficiency; Succinyl-Coa:3-Ketoacid Coa-Transferase Deficiency; Pyridoxine-5'-Phosphate Oxidase Deficiency; Pyridoxine-Dependent Epilepsy; Propionic Acidemia; Pompe Disease; Phenylalanine Hydroxylase Deficiency; Ornithine Transcarbamylase Deficiency; N Acetyl Glutamate Synthetase Deficiency; Riboflavin Deficiency; Maple Syrup Urine Disease; Medium Chain Acyl CoA Dehydrogenase Deficiency; Malonic Acidemia; Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency; Isovaleric Acidemia; Phosphoserine Aminotransferase Deficiency; Phosphoserine Phosphatase Deficiency; Hyperornithinemia-Hyperammonemia-Homocitrullinuria; S-Adenosylhomocysteine Hydrolase Deficiency; Mucopolysaccharidosis VII; Mucopolysaccharidosis VI; Mucopolysaccharidosis IV A; Mucopolysaccharidosis II; Mucopolysaccharidosis I; Transcobalamin Deficiency; Isolated Methylmalonic Acidemia; Cobalamin Deficiency; Homocystinuria; Holocarboxylase Synthetase Deficiency; Fanconi Bickel Syndrome; Glycogen Storage Disease; Glycine Encephalopathy; Glutaric Acidemia I; Glucose Galactose Malabsorption; Gaucher Disease, Type 1; Galactosemias; Fructosemia; Fructose-1,6-Diphosphatase Deficiency; Carbamoyl Phosphate Synthase 1 Deficiency; Citrullinemia Type II; Citrullinemia 1; Creatine Deficiency Syndrome; Systemic Primary Carnitine Deficiency; Carnitine Palmitoyltransferase Deficiency 2; Carnitine Palmitoyltransferase Deficiency 1; Carnitine Acylcarnitine Translocase Deficiency; Riboflavin Transporter Deficiency; Branched-Chain Keto Acid Dehydrogenase Kinase Deficiency; Andersen Tawil Syndrome; Timothy Syndrome; Jervell-Lange Nielsen Syndrome; Catecholaminergic Polymorphic Ventricular Tachycardia; Familial Hypertrophic Cardiomyopathy Type 4; Pseudohypoaldosteronism, Type II; Pseudohypoaldosteronism Type 1; Primary Hyperoxaluria; X Linked Hypophosphatemia; Hereditary Nephrogenic Diabetes Insipidus; Cystinosis; Congenital Nephrotic Syndrome, Finnish Type; Alport Syndrome; Hereditary Retinoblastoma; Biotinidase Deficiency; Aciduria, Argininosuccinic; Argininemia; Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of; 3-Hydroxy 3-Methyl Glutaric Aciduria; 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency
Sponsors: Centre Hospitalier Régional de la Citadelle; Centre Hospitalier Universitaire de Liege; University of Liege; Sanofi; Orchard Therapeutics; Takeda; Zentech-Lacar Company; Leon Fredericq Foundation
Recruiting
-
Posted: December 2nd, 2022, 3:00am GMT
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Mitotane; Drug: Pembrolizumab
Sponsors: M.D. Anderson Cancer Center
Recruiting
-
Posted: September 10th, 2022, 2:00am GMT
Conditions: Medulloblastoma
Interventions: Procedure: Surgical resection; Procedure: Ommaya/VPS; Drug: Methotrexate; Drug: Cisplatin; Drug: Vincristine; Drug: Cyclophosphamide; Drug: Carboplatin; Drug: Topotecan; Drug: Etoposide; Drug: Pegfilgrastim; Drug: Filgrastim; Radiation: Irradiation; Other: Educational and Media Intervention; Other: SOC, Educational and Media Intervention
Sponsors: St. Jude Children's Research Hospital
Recruiting
-
Posted: July 19th, 2022, 2:00am GMT
Conditions: Craniopharyngioma, Child; Craniopharyngioma; Recurrent Craniopharyngioma
Interventions: Drug: Nivolumab; Drug: DAY101
Sponsors: Sabine Mueller, MD, PhD; Bristol-Myers Squibb; Day One Biopharmaceuticals, Inc.
Recruiting
-
Posted: July 13th, 2022, 2:00am GMT
Conditions: Cushing Syndrome; Pheochromocytoma; Conns Syndrome; Metabolic Myopathy
Interventions: Procedure: Muscle biopsy
Sponsors: Barts & The London NHS Trust; Imperial College London; Queen Mary University of London
Terminated
-
Posted: July 7th, 2022, 2:00pm GMT
Conditions: Primary Aldosteronism; Adrenal Cushing Syndrome; Pheochromocytoma; Endocrine Neoplasia
Interventions: Diagnostic Test: Adrenal aldosterone synthase (CYP11B2) staining; Diagnostic Test: Adrenal cortisol synthase (CYP11B1) staining; Diagnostic Test: Histopathological analysis
Sponsors: Helsinki University Central Hospital; Finnish Institute for Health and Welfare; University of Helsinki; Tampere University Hospital; Tampere University
Recruiting
-
Posted: June 29th, 2022, 2:00pm GMT
Conditions: Autonomous Cortisol Secretion (ACS); ACTH-Independent Cushing Syndrome; ACTH-Independent Adrenal Cushing Syndrome, Somatic
Interventions: Drug: SPI-62 dose1; Drug: SPI-62 dose 2; Drug: SPI-62 dose 3; Drug: SPI-62 dose 4; Drug: Placebo
Sponsors: Sparrow Pharmaceuticals
Recruiting
-
Posted: May 11th, 2022, 2:00am GMT
Conditions: Polycystic Ovary Syndrome
Interventions: Drug: Tildacerfont; Drug: Placebo
Sponsors: Spruce Biosciences
Completed
-
Posted: May 10th, 2022, 2:00pm GMT
Conditions: Primary Aldosteronism; Aldosterone-Producing Adenoma
Interventions: Procedure: EUS-RFA of left adrenal gland; Procedure: adrenalectomy
Sponsors: Haukeland University Hospital
Recruiting
-
Posted: April 26th, 2022, 2:00pm GMT
Condition: Colon Neoplasm
Interventions: Drug: Tranexamic acid; Drug: Standard
Sponsor: Assaf-Harofeh Medical Center
Recruiting
-
Posted: April 26th, 2022, 2:00pm GMT
Condition: Cancer
Intervention: Behavioral: Survivorship Care Plan-Personal Health Record (SCP-PHR)
Sponsors: Indiana University; National Cancer Institute (NCI)
Recruiting
-
Posted: April 1st, 2022, 2:00am GMT
Conditions: Cushing's Syndrome I; Cushing Disease Due to Increased ACTH Secretion; Cortisol Excess; Cortisol; Hypersecretion; Cortisol Overproduction; Ectopic ACTH Secretion
Interventions: Drug: SPI-62; Drug: Placebo
Sponsors: Sparrow Pharmaceuticals
Recruiting
-
Posted: March 29th, 2022, 2:00am GMT
Conditions: Breast Cancer
Interventions: Procedure: TAP block; Procedure: QL Block
Sponsors: Ottawa Hospital Research Institute
Withdrawn
-
Posted: February 14th, 2022, 3:00pm GMT
Conditions: Neuroendocrine Tumors; Carcinoma, Neuroendocrine
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: January 20th, 2022, 3:00pm GMT
Condition: Solid Tumors With PTCH1 Loss-of-function Mutations
Intervention: Drug: ENV-101 (taladegib)
Sponsor: Endeavor Biomedicines, Inc.
Recruiting
-
Posted: December 21st, 2021, 3:00pm GMT
Conditions: Analgesia; Thoracic Tumors; Abdomen Tumors; Rib Fractures
Intervention: Procedure: Real-time ultrasound guidance for thoracic epidural catheter placement.
Sponsor: University of Chile
Not yet recruiting
-
Posted: December 2nd, 2021, 3:00pm GMT
Conditions: Adrenal Gland Pheochromocytoma; Hematopoietic and Lymphoid System Neoplasm; Malignant Solid Neoplasm; Paraganglioma
Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Talazoparib; Drug: Temozolomide
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: November 23rd, 2021, 3:00pm GMT
Condition: Breast Cancer Female
Intervention: Procedure: Supine MRI
Sponsors: Dartmouth-Hitchcock Medical Center; CairnSurgical, Inc.
Recruiting
-
Posted: September 5th, 2021, 2:00am GMT
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Pembrolizumab / Lenvatinib
Sponsors: National Cancer Center, Korea; MSD Korea Ltd.
Enrolling by invitation
-
Posted: August 19th, 2021, 2:00pm GMT
Conditions: Solid Tumors; Head and Neck Carcinoma; Cholangiocarcinoma; Sarcoma; Lung Adenocarcinoma; Bladder Urothelial Carcinoma; Stomach Adenocarcinoma; Breast Cancer Invasive; Ovarian Carcinoma; Cervical Cancer; Non Small Cell Lung Cancer; Gastric Cancer; Biliary Tract Cancer; Melanoma; Pancreas Cancer; MDM2 Gene Amplification; Testicular Germ Cell Tumor; Adrenocortical Carcinoma
Interventions: Drug: RAIN-32
Sponsors: Rain Oncology Inc
Terminated
-
Posted: August 10th, 2021, 2:00pm GMT
Condition: Colorectal Cancer Metastatic
Interventions: Behavioral: Hypnosis; Behavioral: CBT
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle
Recruiting
-
Posted: July 21st, 2021, 2:00pm GMT
Condition: Tobacco Use
Interventions: Other: Ventilated Cigarette Filter; Other: Unventilated Cigarette Filter
Sponsors: Masonic Cancer Center, University of Minnesota; Ohio State University
Recruiting
-
Posted: July 19th, 2021, 2:00pm GMT
Conditions: Head and Neck Cancer; Surgery--Complications; Graft Failure
Intervention: Procedure: Tumescence During STSG Harvest
Sponsor: University of California, Davis
Recruiting
-
Posted: June 25th, 2021, 2:00pm GMT
Condition: Metastatic Carcinoma
Intervention: Radiation: Stereotactic ablative body radiation therapy
Sponsors: Baptist Health South Florida; Viewray Inc.
Recruiting
-
Posted: May 28th, 2021, 2:00am GMT
Conditions: Adrenal Tumor; Adrenalectomy; Status
Sponsors: Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Recruiting
-
Posted: May 21st, 2021, 2:00pm GMT
Conditions: Pediatric Solid Tumor; Osteosarcoma; Rhabdomyosarcoma; Neuroblastoma; Ewing Sarcoma; Wilms Tumor; Adrenocortical Cancer; Desmoplastic Small Round Cell Tumor; Germ Cell Cancer; Rhabdoid Tumor; Clear Cell Sarcoma; Hepatoblastoma; Melanoma; Carcinoma; Malignant Peripheral Nerve Sheath Tumors; Soft Tissue Sarcoma
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: MESNA; Drug: B7-H3 CAR T cells
Sponsor: St. Jude Children's Research Hospital
Recruiting
-
Posted: April 27th, 2021, 2:00pm GMT
Conditions: Malignant Adrenal Gland Pheochromocytoma; Malignant Paraganglioma; Pheochromocytoma, Metastatic; Paraganglioma, Malignant; Paraganglioma, Extra-Adrenal
Intervention: Drug: anlotinib hydrochloride
Sponsor: Peking Union Medical College Hospital
Recruiting
-
Posted: March 9th, 2021, 3:00pm GMT
Conditions: Paraganglioma; Pheochromocytoma; Genetic Predisposition to Disease; Pathology; Somatic Mutation; Head and Neck Cancer; Neuroendocrine Tumors
Intervention:
Sponsor: Rigshospitalet, Denmark
Not yet recruiting
-
Posted: March 5th, 2021, 3:00am GMT
Conditions: Advanced Lung Carcinoma; Advanced Malignant Solid Neoplasm; Malignant Adrenal Gland Neoplasm; Metastatic Liver Carcinoma; Metastatic Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Stage III Liver Cancer; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Liver Cancer; Stage IV Lung Cancer AJCC v8; Stage IVA Liver Cancer; Stage IVA Lung Cancer AJCC v8; Stage IVB Liver Cancer; Stage IVB Lung Cancer AJCC v8
Interventions: Biological: Anti-CTLA4 Monoclonal Antibody BMS-986218; Biological: Nivolumab; Radiation: Stereotactic Body Radiation Therapy
Sponsors: M.D. Anderson Cancer Center
Active, not recruiting
-
Posted: March 1st, 2021, 3:00pm GMT
Condition: Smoldering Plasma Cell Myeloma
Interventions: Drug: Dexamethasone; Drug: Iberdomide Hydrochloride; Other: Quality-of-Life Assessment
Sponsors: Emory University; Bristol-Myers Squibb; National Cancer Institute (NCI)
Recruiting
-
Posted: February 5th, 2021, 3:00pm GMT
Conditions: Breast Cancer; Lung Cancer; Colon Cancer; Solid Tumor, Adult
Interventions: Behavioral: PEPRR; Behavioral: Pep-Pal
Sponsors: University of Colorado, Denver; National Cancer Institute (NCI)
Recruiting
-
Posted: November 5th, 2020, 3:00pm GMT
Conditions: Urothelial Carcinoma; Cancer
Intervention: Drug: Patients receiving neoadjuvant therapy before radical nephrectomy
Sponsors: Centre Hospitalier Universitaire de Nīmes; Pitié-Salpêtrière Hospital; Hôpital Bichat-Claude Bernard, 75018 Paris; Hopital Foch 92151 Suresnes; Institut Paoli-Calmettes; European Georges Pompidou Hospital; Saint-Louis Hospital, Paris, France; Centre Hospitalier Lyon Sud; Center Eugene Marquis; IUCT ONCOPOLE
Recruiting
-
Posted: October 20th, 2020, 2:00am GMT
Conditions: Neoplasms, Colorectal
Interventions: Procedure: Endoscopic mucosal resection (EMR); Procedure: Endoscopic submucosal dissection (ESD)
Sponsors: José Carlos Marín Gabriel; Spanish Society of Digestive Endoscopy
Recruiting
-
Posted: July 9th, 2020, 2:00am GMT
Conditions: Prader-Willi Syndrome; PWS-like Syndrome; Silver Russel Syndrome; Congenital Hypopituitarism; Klinefelter (XXY-)Syndrome; Congenital Adrenal Hyperplasia; XXXXY Syndrome; XXYY Syndrome; XXXX Syndrome (Tetra-X Syndrome); Disorders of Sex Development; Turner Syndrome; 46, XY DSD; Tuberous Sclerosis; Neurofibromatosis; Albright Hereditaire Osteodystrofie; Cornelia de Lange Syndrome; Saethre-Chotzen Syndrome; 17p- Deletiesyndrome; VCF Syndrome; POLR3A Mutatie; Ohdo Syndrome; Jacobsen Syndrome / 11 q Syndrome; Myrhe Syndrome; CHARGE Syndrome; 1q25-32 Deletie; Bardet Biedl Syndrome; Rett Syndrome; 22q11 Deletion Syndrome; Allan-Herndon-Dudley Syndrome; Kallmann Syndrome; Rare Bone Disorders; Noonan Syndrome; Williams-Beuren Syndrome
Interventions: Diagnostic Test: Retrospective file studies
Sponsors: dr. Laura C. G. de Graaff-Herder
Recruiting
-
Posted: June 19th, 2020, 2:00am GMT
Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Hematopoietic and Lymphoid Cell Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Multiple Myeloma
Interventions: Drug: Trametinib Dimethyl Sulfoxide
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: June 16th, 2020, 2:00pm GMT
Conditions: Neuroendocrine Tumors; Adrenal Tumor
Interventions: Other: No intervention
Sponsors: University of Pennsylvania
Not yet recruiting
-
Posted: June 2nd, 2020, 2:00am GMT
Conditions: Skin Cancer
Interventions: Device: Nevisense 3.0; Device: Dermlite Cam; Procedure: Skin biopsy
Sponsors: NYU Langone Health
Active, not recruiting
-
Posted: April 22nd, 2020, 2:00am GMT
Conditions: Adrenocortical Carcinoma
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: April 21st, 2020, 2:00am GMT
Conditions: Polycystic Ovarian Syndrome in Adolescent Females; Vitamin D Deficiency
Interventions: Drug: Vitamin D 4000IU daily; Drug: Placebo
Sponsors: Yale University
Not yet recruiting
-
Posted: March 16th, 2020, 2:00am GMT
Conditions: Hypercortisolism
Interventions: Drug: relacorilant; Other: Placebo
Sponsors: Corcept Therapeutics
Recruiting
-
Posted: December 10th, 2019, 3:00pm GMT
Condition: Colorectal Cancer
Interventions: Other: virtual technology - high interactive; Other: virtual technology - low interactive; Other: non-colorectal cancer related module
Sponsors: University of Florida; National Cancer Institute (NCI)
Recruiting
-
Posted: November 20th, 2019, 3:00am GMT
Conditions: Chemotherapy-Induced Peripheral Neuropathy; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
Interventions: Behavioral: Whole Body Vibration
Sponsors: OHSU Knight Cancer Institute; Oregon Health and Science University
Completed
-
Posted: October 3rd, 2019, 2:00am GMT
Conditions: Pancreas Cancer; Lung Cancer; Renal Cancer; Adrenal Metastases; Prostate Cancer; Liver Metastases; Oligoprogressive Nodal Metastases; Metachronous Nodal Metastases; Synchronous Nodal Metastases; Mesothelioma; Spine Metastases; Brain Metastases; Borderline Resectable Pancreatic Carcinoma
Interventions: Radiation: MR-guided Linac
Sponsors: Dana-Farber Cancer Institute
Suspended
-
Posted: July 22nd, 2019, 2:00am GMT
Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma; Pulmonary Carcinoma
Interventions: Diagnostic Test: Biomarker Testing (L); Drug: Systemic Treatment (T); Other: Patient Reported Outcomes (P)
Sponsors: Taproot Health
Recruiting
-
Posted: June 7th, 2019, 2:00pm GMT
Conditions: Breast Cancer; Nerve Block; Regional Anesthesia; Neuromuscular Blockade
Interventions: Procedure: Erector spinae plane block; Procedure: Placebo Block
Sponsor: Women's College Hospital
Not yet recruiting
-
Posted: April 5th, 2019, 2:00am GMT
Conditions: Polycystic Ovary Syndrome
Interventions: Drug: ACTH; Drug: rhCG
Sponsors: University of Virginia
Recruiting
-
Posted: March 6th, 2019, 3:00am GMT
Conditions: Polycystic Ovary Syndrome; Anovulation; Hyperandrogenism; Insulin Resistance; Glucose Intolerance; Metabolic Complication
Interventions: Other: Placebo; Drug: Inositol
Sponsors: Milton S. Hershey Medical Center; National Center for Complementary and Integrative Health (NCCIH)
Recruiting
-
Posted: March 5th, 2019, 3:00pm GMT
Condition: Metastatic Tumors
Interventions: Radiation: palliative radiotherapy; Radiation: Stereotactic ablative radiotherapy
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; The Alfred; Beacon Hospital, Ireland; Cancer Trials Ireland; Cancer Research UK Edinburgh Centre; Bon Secours Cork Cancer Centre; UPMC Hillman Cancer Centre; Beatson West of Scotland Cancer Centre; Tom Baker Cancer Centre; Walker Family Cancer Centre; Riverina Cancer Care Centre
Recruiting
-
Posted: February 6th, 2019, 3:00am GMT
Conditions: Cushing Disease
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
-
Posted: November 20th, 2018, 3:00pm GMT
Condition: Renal Tumor
Intervention: Radiation: Stereotactic Ablative Radiotherapy
Sponsor: University Health Network, Toronto
Recruiting